RY8 — Rongyu Pharmaceuticals Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Rongyu Pharmaceuticals, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | AAS | AAS | AAS |
| Status: | Final | Final | Final |
| Changes in Working Capital | 0.036 | 0.052 | 0.043 |
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 12.1 | 12.3 | 11.3 |
| Capital Expenditures | -0.001 | -3 | -0.009 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.001 | -3 | -0.009 |
| Financing Cash Flow Items | 0.025 | 0 | -0.006 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -9.77 | -16 | -0.006 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 3.94 | -6.72 | 10.7 |